Scale‐Down Model Development in ambr systems: An Industrial Perspective
Open accessThe DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Abstract
High‐Throughput (HT) technologies such as miniature bioreactors (MBRs) are increasingly employed within the biopharmaceutical manufacturing industry. Traditionally, these technologies have been utilized for discrete screening approaches during pre‐clinical development (e.g., cell line selection and process optimization). However, increasing interest is focused towards their use during late clinical phase process characterization studies as a scale‐down model (SDM) of the cGMP manufacturing process. In this review, the authors describe a systematic approach toward SDM development in one of the most widely adopted MBRs, the ambr 15 and 250 mL (Sartorius Stedim Biotech) systems. Recent efforts have shown promise in qualifying ambr systems as SDMs to support more efficient, robust and safe biomanufacturing processes. The authors suggest that combinatorial improvements in process understanding (matching of mass transfer and cellular stress between scales through computational fluid dynamics and in vitro analysis), experimental design (advanced risk assessment and statistical design of experiments), and data analysis (combining uni‐ and multi‐variate techniques) will ultimately yield ambr SDMs applicable for future regulatory submissions.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In recent years, automated parallel bioreactor systems have accelerated fermentation process development by combining smaller volumes and higher throughput to enable greater iteration than traditional benchtop bioreactors84–86.”
From Developing a new class of engineered live bacterial therapeutics to treat human diseases (2020) · cites this paper as [85]
Citations
Cites
Quality by design for biopharmaceuticals
Rathore, A. S., & Winkle, H. (2009) · Nature Biotechnology · doi:10.1038/nbt0109-26 · Cited by 830
Cell culture processes for monoclonal antibody production
Li, F., Vijayasankaran, N., Shen, A. (., Kiss, R., & Amanullah, A. (2010) · mAbs · doi:10.4161/mabs.2.5.12720 · Cited by 739
Quality by Design in Biopharmaceuticals
Yang, H. (2016) · doi:10.1201/9781315371726-7 · Cited by 543
Reactor Engineering in Large Scale Animal Cell Culture
Nienow, A. W. (2006) · Cytotechnology · doi:10.1007/s10616-006-9005-8 · Cited by 433
Scale‐up analysis for a CHO cell culture process in large‐scale bioreactors
Xing, Z., Kenty, B. M., Li, Z. J., & Lee, S. S. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22287 · Cited by 228
Computational fluid dynamics for improved bioreactor design and 3D culture
Hutmacher, D. W., & Singh, H. (2008) · Trends in Biotechnology · doi:10.1016/j.tibtech.2007.11.012 · Cited by 222
Trummer, E., Fauland, K., Seidinger, S., Schriebl, K., Lattenmayer, C., Kunert, R., Vorauer‐Uhl, K., Weik, R., Borth, N., Katinger, H., et al. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.21013 · Cited by 216
Bareither, R., & Pollard, D. (2011) · Biotechnology Progress · doi:10.1002/btpr.522 · Cited by 205
Jesus, M. J. D., Girard, P., Bourgeois, M., Baumgartner, G., Jacko, B., Amstutz, H., & Wurm, F. M. (2003) · Biochemical Engineering Journal · doi:10.1016/s1369-703x(03)00180-3 · Cited by 154
Advanced microscale bioreactor system: a representative scale-down model for bench-top bioreactors
Hsu, W.-T., Aulakh, R. P. S., Traul, D. L., & Yuk, I. H. Y. (2012) · Cytotechnology · doi:10.1007/s10616-012-9446-1 · Cited by 143
Research works printed but not linked: 9
- Banerjee A., 2010, BioPharm Int, 23, 26
- Chen A., 2009, Biotechnol. Bioeng, 102, 48
- Marks D. M., 2003, Cytotechnology, 103, 733
- de Wilde D., 2014, BioProcess Int
- Shivhare M., 2010, BioProcess Int, 8, 22
- McCreath G., 2011, EBR, 62
- DeCesare C., 2016, Bioprocess Int, 14, 18
- Spann R., 2018, Ref. Mod. Chem. Mol. Sci. Chem. Eng, 1
- Anane E., 2018, J. Chem. Technol. Biotechnol, 0268
Cited by
Tripathi, N. K., & Shrivastava, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00420 · Cited by 575
Developing a new class of engineered live bacterial therapeutics to treat human diseases
Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020) · Nature Communications · doi:10.1038/s41467-020-15508-1 · Cited by 523
High-Throughput Screening Technology in Industrial Biotechnology
Zeng, W., Guo, L., Xu, S., Chen, J., & Zhou, J. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2020.01.001 · Cited by 317
Ayon, N. J. (2023) · Metabolites · doi:10.3390/metabo13050625 · Cited by 183
Developing therapeutic monoclonal antibodies at pandemic pace
Kelley, B. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0512-5 · Cited by 163
Metadata
- Authors
- Sandner, V., Pybus, L. P., McCreath, G., & Glassey, J.
- Affiliations
- Fujifilm (United Kingdom) (GB)
- Newcastle University (GB)
- Corresponding author
- Sandner, Viktor
- Venue
- Biotechnology Journal
- Publisher
- Wiley
- Published
- 2018-11-26
- Volume
- 14
- Issue
- 4
- Pages
- e1700766-e1700766
- ISSN
- 1860-6768 (ISSN-L)
- 1860-7314
- OpenAlex
- W2895809414
- Cited by
- 63
- References
- 60
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 6 · 2023: 9 · 2022: 9 · 2021: 9 · 2020: 8 · 2019: 5
- FWCI
- 0.45
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Biotechnology Journal (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- H2020 Marie Skłodowska-Curie Actions (643056)
- Topics
- Physical Sciences › Chemical Engineering › Fluid Flow and Transfer Processes › Fluid Dynamics and Mixing
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Keywords
- scale-down model, biopharmaceutical manufacturing, process characterization, cGMP production, mass transfer, cellular stress, computational fluid dynamics, experimental design, risk assessment, multivariate analysis, regulatory submissions
- MeSH terms
- Animals, Cricetulus, Cyclic GMP, Cricetinae, Industry, CHO Cells, Bioreactors, High-Throughput Screening Assays, Hydrodynamics, Batch Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Scale‐Down Model Development in ambr systems: An Industrial Perspective. https://app.cochat.ai/papers/10.1002/biot.201700766
- The paper
- Sandner, V., Pybus, L. P., McCreath, G., & Glassey, J. (2019). Scale‐Down Model Development in ambr systems: An Industrial Perspective. Biotechnology Journal. https://doi.org/10.1002/biot.201700766
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.